Skip to main content
. 2018 Oct 30;1(5):e201800171. doi: 10.26508/lsa.201800171

Figure S1.

Figure S1.

(A) Distribution of LATS2 mRNA expression levels in different breast cancer subtypes (PAM50, METABTIC dataset); ***P-value < 0.001, t test comparing lumB tumors with all other subtypes. Number of tumors of each subtype is indicated at the bottom. (B) Kaplan–Meier plot of relapse-free survival (RFS) probability of lumB breast cancer patients separated according to LATS2 expression levels (n = 407, KM-plotter [Györffy et al, 2010]).